SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001372514-24-000065
Filing Date
2024-06-14
Accepted
2024-06-14 16:47:33
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718398034.html 4  
1 FORM 4 wk-form4_1718398034.xml 4 3180
  Complete submission text file 0001372514-24-000065.txt   4790
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KIORA PHARMACEUTICALS, INC. 1371 EAST 2100 SOUTH, SUITE 200 SALT LAKE CITY UT 84105
Business Address
Tosca Melissa (Reporting) CIK: 0001947184 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 241045590